Results 41 to 50 of about 1,959 (184)
Benchmark of Open-Access Star-Allele Callers to Accurately Assess Haplotypes and Phenotypes in Pharmacogenetic Studies. [PDF]
Genetic polymorphisms are common in pharmacogenes, with sometimes important implications for drug metabolism. Assessing the correct enzyme phenotype from genetic data is thus a crucial step into the development of personalized medicine. Many bioinformatics star‐allele callers have been developed for this purpose of identifying the correct star alleles ...
Gros-La-Faige MB, Génin E, Herzig AF.
europepmc +2 more sources
Background: 6-Mercaptopurine (6-MP) is the cornerstone of current antileukemia regimen and contributes greatly to improve the survival of pediatric acute lymphoblastic leukemia (ALL) patients.
Xiaoyan Mao +11 more
doaj +1 more source
NUDT15: a novel player in thiopurine metabolism
.
Meijer, Berrie +2 more
openaire +3 more sources
Backgound: The high incidence of thiopurine-induced myelosuppression in Asians is known to be attributable to genetic variation in thiopurine metabolism.
Napat Laoaroon (11780597) +11 more
core +1 more source
Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review [PDF]
The development of treatment options has revolutionized the prognosis of inflammatory bowel disease (IBD). However, a particular group of patients still experience therapeutic failure or drug side effects.
Ji Young Chang, Jae Hee Cheon
doaj +1 more source
NUDT15 Genetic Polymorphism as a Risk Factor for Early Neutropenia During Valganciclovir Prophylaxis in Lung Transplant Patients. [PDF]
Background: Valganciclovir (VGCV) prophylaxis effectively prevents cytomegalovirus infection in lung transplant patients. However, VGCV-induced neutropenia causes early cessation.
Katsube Y +13 more
europepmc +2 more sources
Mercaptopurine (MP) is a commonly used maintenance regimen for childhood acute lymphoblastic leukemia (ALL). However, 6-MP has a narrow therapeutic index, which causes dose-limiting toxicities in hematopoietic tissues.
Jae Min Lee +4 more
doaj +1 more source
Mercaptopurine induced myelosuppression in a child with a NUDT15 rs116855232 homozygous variant
Introduction Mercaptopurine (6-MP) is the backbone of the consolidation and maintenance therapy for paediatric acute lymphoblastic leukaemia (ALL). Nevertheless, it can cause critical myelosuppression. Predicting adverse reactions to 6-MP often involves the investigation of pharmacogenetic variants; in ...
Navya Gupta +5 more
openaire +5 more sources
NUDT15 as potential marker for pharmacogenetic-guided 6-mercaptopurine therapy in children with acute lymphoblastic leukemia in Serbia [PDF]
Introduction: The NUDT15 is new pharmacogene of importance for 6-mercaptopurine therapy, given to children with acute lymphoblastic leukemia (ALL).
Jelovac, Marina +9 more
core
Background Polymorphisms in thiopurine methyltransferase (TPMT) and Nudix hydrolase-15 (NUDT15) have been implicated as the predominant cause of thiopurine induced leukopenia in the Western countries and East Asia respectively.
Narinder Grover +9 more
doaj +1 more source

